Table 1

Eligibility criteria

All modules
  1. Patient has a confirmed primary pancreatic, oesophageal, gastric, liver, biliary or gall bladder cancer with some limited exclusions specified in each module (see below).

  2. Patient has been assessed or received care at a participating public or private hospital or private clinician rooms.

  3. Patient is 18 years of age or older at time of diagnosis.

  4. Patient has a diagnosis date on or after 1 January 2016 (apart from one centre that commenced recruitment in November 2015).

Module specific
ModulesTumour sitesTumour cell types
Pancreatic Inclusion Pancreas.
Periampullary region
  • Ampulla of Vater.

  • Biliary origin.

  • Intestinal origin.

Distal bile duct.
Ductal adenocarcinoma.
Acinar cell carcinoma.
Acinar cell cystadenocarcinoma.
IPMN (invasive).
Serous cystadenocarcinoma.
Exclusion Non-distal bile ductNeuroendocrine neoplasms.
Premalignant lesions.
Mesenchymal tumours.
Solid pseudopapilliary carcinoma.
IPMN (non-invasive).
Oesophagogastric Inclusion Oesophagus (lower two-thirds).
Gastro-oesophageal junction.
  • Adenocarcinoma.

  • Squamous cell carcinoma.

  • Other subtypes.

Exclusion Upper third of oesophagus.Neuroendocrine neoplasms.
Mesenchymal tumours.
Biliary Inclusion Perihilar (hilar) bile duct.
Intrahepatic bile duct.
Gall bladder.
 Adenosquamous carcinoma.
 Squamous cell carcinoma.
Exclusion Distal bile duct.Neuroendocrine neoplasms.
Mesenchymal tumours.
Liver* Inclusion Liver.Hepatocellular carcinoma.
Exclusion Intrahepatic bile duct.Cholangiocarcinoma.
Mesenchymal tumours.
Germ cell tumours.
  • *Liver module eligibility criteria still to be finalised.

  • IPMN, intraductal papillary mucinous neoplasm.